Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Swift Molecular Diagnostics

Swift Molecular Diagnostics
PRIVATE STATUS
1-10 EMPLOYEES
Accelerator/Inc LATEST DEAL TYPE
1 INVESTORS
Description

Developer of a genetic fingerprint detection technology. The company develops a technology that enables diagnostic devices to detect genetic and antibiotic resistance and facilitate treatment of bacterial infections.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Biotechnology
Primary Office
  • Department of Genetics
  • University of Cambridge, Downing Street
  • Cambridge CB2 3EH
  • England, United Kingdom
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Swift Molecular Diagnostics’s full profile, request a free trial.

Swift Molecular Diagnostics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Swift Molecular Diagnostics Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Accelerate Cambridge Accelerator/Incubator 000 0000 000000 0

Swift Molecular Diagnostics Executive Team (2)

Name Title Board
Seat
Contact
Info
Benjamin Shaw Chief Executive Officer
Gustavo Cerda-Moya Ph.D Inventor & Chief Technology Officer